Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Shares IssuedShares OutstandingShares Outstanding
Ratios

Aura Biosciences (AURA) Leases (2021 - 2026)

Aura Biosciences filings provide 6 years of Leases readings, the most recent being $15.4 million for Q1 2026.

  • Quarterly Leases fell 9.34% to $15.4 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $15.4 million through Mar 2026, down 9.34% year-over-year, with the annual reading at $15.8 million for FY2025, 8.92% down from the prior year.
  • Leases hit $15.4 million in Q1 2026 for Aura Biosciences, down from $15.8 million in the prior quarter.
  • Across five years, Leases topped out at $21.0 million in Q3 2022 and bottomed at $656000.0 in Q2 2022.
  • Average Leases over 5 years is $16.2 million, with a median of $17.7 million recorded in 2024.
  • The largest annual shift saw Leases soared 2949.24% in 2023 before it fell 9.34% in 2026.
  • Aura Biosciences' Leases stood at $20.7 million in 2022, then fell by 8.79% to $18.9 million in 2023, then dropped by 7.82% to $17.4 million in 2024, then fell by 8.92% to $15.8 million in 2025, then fell by 2.6% to $15.4 million in 2026.
  • Per Business Quant, the three most recent readings for AURA's Leases are $15.4 million (Q1 2026), $15.8 million (Q4 2025), and $16.2 million (Q3 2025).